HTR1A and bipolar disorder: The initial antidepressant effects of lurasidone in people with bipolar depression are associated with its ability to reduce norepinephrine inhibition through its agonistic activity at 5‐HT1A receptors and antagonistic activity at alpha‐1 norepinephrine and serotonin 5‐HT2A receptors [45, 46].